This universal effect indicates that PPARγ is a significant player in the GBA communication, either directly or indirectly, and can be among the clinical targets of future probiotic or synbiotic therapies in the management of chronic multifactorial diseases such as AD. Here, PPARG is linked to Alzheimer disease.